MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia

Gordon A Awandare1, Jeremy J Martinson, Tom Were

  • 1Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Abstract

Insights

Genetic variations in macrophage migration inhibitory factor (MIF) influence susceptibility to severe malarial anemia (SMA). Specific MIF haplotypes offer protection, while others increase SMA risk and reduce MIF levels in children.

Area of Science:

  • Immunogenetics
  • Infectious Disease Pathogenesis
  • Human Genetics

Background:

  • Severe malarial anemia (SMA) is a major cause of child mortality in sub-Saharan Africa.
  • Macrophage migration inhibitory factor (MIF) is an innate immune mediator critical in SMA pathogenesis.

Purpose of the Study:

  • To investigate the impact of genetic variations in the MIF gene promoter on susceptibility to SMA.
  • To analyze the relationship between MIF polymorphisms and MIF production in children.

Main Methods:

  • Examined haplotypes of MIF -173G/C and -794CATT5-8 polymorphisms in Kenyan children.
  • Utilized multivariate logistic regression to assess associations with SMA severity and plasma MIF levels.

Main Results:

  • Longer CATT repeats at the -794 locus correlated with increased SMA severity.
  • The 6G haplotype provided protection against SMA, while 7C and 8C haplotypes increased risk.
  • Longer CATT repeats and 7C/8C haplotypes were associated with lower plasma MIF levels.

Conclusions:

  • MIF promoter variations significantly influence SMA susceptibility and peripheral MIF production.
  • MIF polymorphisms exhibit complex, interactive effects on SMA pathogenesis and disease severity.
  • Genetic variation in MIF plays a crucial role in the host response to Plasmodium falciparum infection.